BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lifeblood Medical, Inc. Receives Notice of Allowance for U.S. Patent


3/28/2007 11:15:41 AM

ADELPHIA, N.J., March 28 /PRNewswire/ -- Lifeblood Medical, Inc. is pleased to announce that it has received a Notice of Allowance from the U.S. Patent Office for its patent application titled, "Composition for Maintaining Organ and Cell Viability." The allowed claim provides patent protection for Lifeblood's proprietary solutions related to the prolonged preservation of organs, tissues and cells, and particularly for the preservation of organs donated for transplantation, as well as methods of making and using the same.

"We are extremely pleased with the allowance of our first patent," stated Joseph Fischer, President and Chief Executive Officer of Lifeblood Medical, Inc. "This patent, once issued, will provide Lifeblood with significant intellectual property protection to support Lifor(R) for FDA approval for heart preservation and transportation. We also have additional pending U.S. patent applications directed to other aspects of the technology including related compositions, method of making and using the proprietary solutions and the Lifor(R) technology for preservation and transportation of a multitude of organs, cells and tissues."

About Lifeblood Medical, Inc.

Lifeblood Medical, Inc., headquartered in Adelphia N.J., is a cell culture/biotech company whose goal is to enhance and extend the quality of life in the field of organ, cell and tissue preservation through the utilization of our proprietary solutions and by providing key reagents to the research community.

We distribute high quality serum and reagents to the research community at competitive prices. Our products include Serum, Serum Enhancers, Antibiotics and Specialty Media.

Our proprietary solution is considered platform enabling technology, with the potential to address a multitude of applications through all segments of the tissue, cell and organ transplant markets by way of its unique serum free, animal protein free and oxygen carrying properties. For the cell and tissue preservation market we offer LiforCell(R). For whole organ preservation, transportation and transplantation we offer LIFOR(R). LIFOR(R) is currently undergoing clinical trials for the support of heart and kidney harvesting, transporting and reimplantation. FDA submission is anticipated later this year. Additional information is available online at http://www.lifebloodmedical.com/.

Lifeblood Medical, Inc.

CONTACT: Joseph Fischer of Lifeblood Medical, Inc., +1-732-431-5833



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES